{"count": 11, "results": [{"_id": "34489707", "pmid": 34489707, "pmcid": "PMC8417441", "title": "Interference With the AMPKalpha/mTOR/NLRP3 Signaling and the IL-23/IL-17 Axis Effectively Protects Against the Dextran Sulfate Sodium Intoxication in Rats: A New Paradigm in Empagliflozin and Metformin Reprofiling for the Management of Ulcerative Colitis", "journal": "Front Pharmacol", "authors": ["Youssef ME", "Abd El-Fattah EE", "Abdelhamid AM", "Eissa H", "El-Ahwany E", "Amin NA", "Hetta HF", "Mahmoud MH", "Batiha GE", "Gobba N", "Ahmed Gaafar AG", "Saber S"], "date": "2021-08-16T00:00:00Z", "doi": "10.3389/fphar.2021.719984", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "719984", "score": 50271.957, "text_hl": "In the present research, we investigated the effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @CHEMICAL_empagliflozin @CHEMICAL_MESH:C570240 @@@empagliflozin@@@, or their combined therapy in a @CHEMICAL_Dextran_Sulfate @CHEMICAL_MESH:D016264 @@@DSS@@@-induced @SPECIES_10090 @@@murine@@@ model of @<m>DISEASE_Colitis_Ulcerative</m> @DISEASE_MESH:D003093 @@@ulcerative colitis@@@. ", "citations": {"NLM": "Youssef ME, Abd El-Fattah EE, Abdelhamid AM, Eissa H, El-Ahwany E, Amin NA, Hetta HF, Mahmoud MH, Batiha GE, Gobba N, Ahmed Gaafar AG, Saber S. Interference With the AMPKalpha/mTOR/NLRP3 Signaling and the IL-23/IL-17 Axis Effectively Protects Against the Dextran Sulfate Sodium Intoxication in Rats: A New Paradigm in Empagliflozin and Metformin Reprofiling for the Management of Ulcerative Colitis Front Pharmacol. 2021;12():719984. PMID: 34489707", "BibTeX": "@article{34489707, title={Interference With the AMPKalpha/mTOR/NLRP3 Signaling and the IL-23/IL-17 Axis Effectively Protects Against the Dextran Sulfate Sodium Intoxication in Rats: A New Paradigm in Empagliflozin and Metformin Reprofiling for the Management of Ulcerative Colitis}, author={Youssef ME and Abd El-Fattah EE and Abdelhamid AM and Eissa H and El-Ahwany E and Amin NA and Hetta HF and Mahmoud MH and Batiha GE and Gobba N and Ahmed Gaafar AG and Saber S}, journal={Front Pharmacol}, volume={12}, pages={719984}}"}}, {"_id": "40191419", "pmid": 40191419, "title": "The adjunctive role of metformin in patients with mild to moderate ulcerative colitis: a randomized controlled study.", "journal": "Front Pharmacol", "authors": ["Binsaleh AY", "El-Haggar SM", "Hegazy SK", "Maher MM", "Bahgat MM", "Elmasry TA", "Alrubia S", "Alsegiani AS", "Eldesoqui M", "Bahaa MM"], "date": "2025-03-19T00:00:00Z", "doi": "10.3389/fphar.2025.1507009", "meta_date_publication": "2025", "meta_volume": "16", "meta_issue": "", "meta_pages": "1507009", "score": 50261.543, "text_hl": "The adjunctive role of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @SPECIES_9606 @@@patients@@@ with mild to moderate @<m>DISEASE_Colitis_Ulcerative</m> @DISEASE_MESH:D003093 @@@ulcerative colitis@@@: a randomized controlled study.", "citations": {"NLM": "Binsaleh AY, El-Haggar SM, Hegazy SK, Maher MM, Bahgat MM, Elmasry TA, Alrubia S, Alsegiani AS, Eldesoqui M, Bahaa MM. The adjunctive role of metformin in patients with mild to moderate ulcerative colitis: a randomized controlled study. Front Pharmacol. 2025;16():1507009. PMID: 40191419", "BibTeX": "@article{40191419, title={The adjunctive role of metformin in patients with mild to moderate ulcerative colitis: a randomized controlled study.}, author={Binsaleh AY and El-Haggar SM and Hegazy SK and Maher MM and Bahgat MM and Elmasry TA and Alrubia S and Alsegiani AS and Eldesoqui M and Bahaa MM}, journal={Front Pharmacol}, volume={16}, pages={1507009}}"}}, {"_id": "35645830", "pmid": 35645830, "pmcid": "PMC9136141", "title": "Metformin Ameliorates Chronic Colitis-Related Intestinal Fibrosis via Inhibiting TGF-beta1/Smad3 Signaling", "journal": "Front Pharmacol", "authors": ["Wang Y", "Wang Z", "Yang H", "Chen S", "Zheng D", "Liu X", "Jiang Q", "Chen Y"], "date": "2022-05-13T00:00:00Z", "doi": "10.3389/fphar.2022.887497", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "887497", "score": 50259.94, "text_hl": "Effective medical therapies or preventive measures are desirable but currently unavailable. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ has been proved to have a satisfactory anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ effects in @<m>DISEASE_Colitis_Ulcerative</m> @DISEASE_MESH:D003093 @@@ulcerative colitis@@@ (@<m>DISEASE_Colitis_Ulcerative</m> @DISEASE_MESH:D003093 @@@UC@@@) @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Wang Y, Wang Z, Yang H, Chen S, Zheng D, Liu X, Jiang Q, Chen Y. Metformin Ameliorates Chronic Colitis-Related Intestinal Fibrosis via Inhibiting TGF-beta1/Smad3 Signaling Front Pharmacol. 2022;13():887497. PMID: 35645830", "BibTeX": "@article{35645830, title={Metformin Ameliorates Chronic Colitis-Related Intestinal Fibrosis via Inhibiting TGF-beta1/Smad3 Signaling}, author={Wang Y and Wang Z and Yang H and Chen S and Zheng D and Liu X and Jiang Q and Chen Y}, journal={Front Pharmacol}, volume={13}, pages={887497}}"}}, {"_id": "34658866", "pmid": 34658866, "pmcid": "PMC8514724", "title": "Metformin Exerts Anti-inflammatory and Mucus Barrier Protective Effects by Enriching Akkermansia muciniphila in Mice With Ulcerative Colitis", "journal": "Front Pharmacol", "authors": ["Ke H", "Li F", "Deng W", "Li Z", "Wang S", "Lv P", "Chen Y"], "date": "2021-09-30T00:00:00Z", "doi": "10.3389/fphar.2021.726707", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "726707", "score": 50257.426, "text_hl": "The underlying mechanism and whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can improve the mucus barrier in @<m>DISEASE_Colitis_Ulcerative</m> @DISEASE_MESH:D003093 @@@UC@@@ remain unclear. ", "citations": {"NLM": "Ke H, Li F, Deng W, Li Z, Wang S, Lv P, Chen Y. Metformin Exerts Anti-inflammatory and Mucus Barrier Protective Effects by Enriching Akkermansia muciniphila in Mice With Ulcerative Colitis Front Pharmacol. 2021;12():726707. PMID: 34658866", "BibTeX": "@article{34658866, title={Metformin Exerts Anti-inflammatory and Mucus Barrier Protective Effects by Enriching Akkermansia muciniphila in Mice With Ulcerative Colitis}, author={Ke H and Li F and Deng W and Li Z and Wang S and Lv P and Chen Y}, journal={Front Pharmacol}, volume={12}, pages={726707}}"}}, {"_id": "33504231", "pmid": 33504231, "title": "Metformin alleviates inflammation in oxazolone induced ulcerative colitis in rats: plausible role of sphingosine kinase 1/sphingosine 1 phosphate signaling pathway.", "journal": "Immunopharmacol Immunotoxicol", "authors": ["El-Mahdy NA", "El-Sayad ME", "El-Kadem AH", "Abu-Risha SE"], "date": "2021-04-01T00:00:00Z", "doi": "10.1080/08923973.2021.1878214", "meta_date_publication": "2021 Apr", "meta_volume": "43", "meta_issue": "2", "meta_pages": "192-202", "score": 50248.613, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ alleviates @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@ in @CHEMICAL_Oxazolone @CHEMICAL_MESH:D010081 @@@oxazolone@@@ induced @<m>DISEASE_Colitis_Ulcerative</m> @DISEASE_MESH:D003093 @@@ulcerative colitis@@@ in @SPECIES_10116 @@@rats@@@: plausible role of @GENE_SPHK1 @GENE_170897 @@@sphingosine kinase 1@@@/@CHEMICAL_sphingosine_1_phosphate @CHEMICAL_MESH:C060506 @@@sphingosine 1 phosphate@@@ signaling pathway.", "citations": {"NLM": "El-Mahdy NA, El-Sayad ME, El-Kadem AH, Abu-Risha SE. Metformin alleviates inflammation in oxazolone induced ulcerative colitis in rats: plausible role of sphingosine kinase 1/sphingosine 1 phosphate signaling pathway. Immunopharmacol Immunotoxicol. 2021 Apr;43(2):192-202. PMID: 33504231", "BibTeX": "@article{33504231, title={Metformin alleviates inflammation in oxazolone induced ulcerative colitis in rats: plausible role of sphingosine kinase 1/sphingosine 1 phosphate signaling pathway.}, author={El-Mahdy NA and El-Sayad ME and El-Kadem AH and Abu-Risha SE}, journal={Immunopharmacol Immunotoxicol}, volume={43}, number={2}, pages={192-202}}"}}, {"_id": "32654569", "pmid": 32654569, "title": "Metformin alleviates experimental colitis in mice by up-regulating TGF-beta signaling.", "journal": "Biotech Histochem", "authors": ["Liu X", "Sun Z", "Wang H"], "date": "2021-02-01T00:00:00Z", "doi": "10.1080/10520295.2020.1776896", "meta_date_publication": "2021 Feb", "meta_volume": "96", "meta_issue": "2", "meta_pages": "146-152", "score": 50248.14, "text_hl": "...@<m>DISEASE_Colitis_Ulcerative</m> @DISEASE_MESH:D003093 @@@Ulcerative colitis@@@ is an @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ condition of the colon. ", "citations": {"NLM": "Liu X, Sun Z, Wang H. Metformin alleviates experimental colitis in mice by up-regulating TGF-beta signaling. Biotech Histochem. 2021 Feb;96(2):146-152. PMID: 32654569", "BibTeX": "@article{32654569, title={Metformin alleviates experimental colitis in mice by up-regulating TGF-beta signaling.}, author={Liu X and Sun Z and Wang H}, journal={Biotech Histochem}, volume={96}, number={2}, pages={146-152}}"}}, {"_id": "35724510", "pmid": 35724510, "title": "Combining the HSP90 inhibitor TAS-116 with metformin effectively degrades the NLRP3 and attenuates inflammasome activation in rats: A new management paradigm for ulcerative colitis.", "journal": "Biomed Pharmacother", "authors": ["Shaaban AA", "Abdelhamid AM", "Shaker ME", "Cavalu S", "Maghiar AM", "Alsayegh AA", "Babalghith AO", "El-Ahwany E", "Amin NA", "Mohammed OA", "Eissa H", "Gaafar AGA", "Batiha GE", "Saber S"], "date": "2022-09-01T00:00:00Z", "doi": "10.1016/j.biopha.2022.113247", "meta_date_publication": "2022 Sep", "meta_volume": "153", "meta_issue": "", "meta_pages": "113247", "score": 50248.023, "text_hl": "Combining the @GENE_HSP90AA1 @GENE_299331 @@@HSP90@@@ inhibitor @CHEMICAL_TAS_116 @CHEMICAL_MESH:C000596495 @@@TAS-116@@@ with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ effectively degrades the @GENE_NLRP3 @GENE_287362 @@@NLRP3@@@ and attenuates inflammasome activation in @SPECIES_10116 @@@rats@@@: A new management paradigm for @<m>DISEASE_Colitis_Ulcerative</m> @DISEASE_MESH:D003093 @@@ulcerative colitis@@@.", "citations": {"NLM": "Shaaban AA, Abdelhamid AM, Shaker ME, Cavalu S, Maghiar AM, Alsayegh AA, Babalghith AO, El-Ahwany E, Amin NA, Mohammed OA, Eissa H, Gaafar AGA, Batiha GE, Saber S. Combining the HSP90 inhibitor TAS-116 with metformin effectively degrades the NLRP3 and attenuates inflammasome activation in rats: A new management paradigm for ulcerative colitis. Biomed Pharmacother. 2022 Sep;153():113247. PMID: 35724510", "BibTeX": "@article{35724510, title={Combining the HSP90 inhibitor TAS-116 with metformin effectively degrades the NLRP3 and attenuates inflammasome activation in rats: A new management paradigm for ulcerative colitis.}, author={Shaaban AA and Abdelhamid AM and Shaker ME and Cavalu S and Maghiar AM and Alsayegh AA and Babalghith AO and El-Ahwany E and Amin NA and Mohammed OA and Eissa H and Gaafar AGA and Batiha GE and Saber S}, journal={Biomed Pharmacother}, volume={153}, pages={113247}}"}}, {"_id": "34986539", "pmid": 34986539, "title": "Metformin alleviates intestinal epithelial barrier damage by inhibiting endoplasmic reticulum stress-induced cell apoptosis in colitis cell model.", "journal": "Zhejiang Da Xue Xue Bao Yi Xue Ban", "authors": ["Wang J", "Chen C", "Ren Y", "Zhou X", "Yu S"], "date": "2021-10-25T00:00:00Z", "doi": "10.3724/zdxbyxb-2021-0242", "meta_date_publication": "2021 Oct 25", "meta_volume": "50", "meta_issue": "5", "meta_pages": "627-632", "score": 50242.94, "text_hl": "To investigate the effect and mechanism of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on intestinal epithelial barrier injury in @<m>DISEASE_Colitis_Ulcerative</m> @DISEASE_MESH:D003093 @@@ulcerative colitis@@@. ", "citations": {"NLM": "Wang J, Chen C, Ren Y, Zhou X, Yu S. Metformin alleviates intestinal epithelial barrier damage by inhibiting endoplasmic reticulum stress-induced cell apoptosis in colitis cell model. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021 Oct 25;50(5):627-632. PMID: 34986539", "BibTeX": "@article{34986539, title={Metformin alleviates intestinal epithelial barrier damage by inhibiting endoplasmic reticulum stress-induced cell apoptosis in colitis cell model.}, author={Wang J and Chen C and Ren Y and Zhou X and Yu S}, journal={Zhejiang Da Xue Xue Bao Yi Xue Ban}, volume={50}, number={5}, pages={627-632}}"}}, {"_id": "20301489", "pmid": 20301489, "title": "Glycogen Storage Disease Type I", "journal": "", "authors": ["Adam MP", "Everman DB", "Mirzaa GM", "Pagon RA", "Wallace SE", "Bean LJH", "Gripp KW", "Amemiya A", "Bali DS", "El-Gharbawy A", "Austin S", "Pendyal S", "Kishnani PS"], "date": "2021-10-14T00:00:00Z", "meta_date_publication": "1993", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50212.984, "text_hl": "Combined oral contraception (including high-dose estrogen) should be avoided in @SPECIES_9606 @@@women@@@, particularly those with @DISEASE_Adenoma @DISEASE_MESH:D000236 @@@adenomas@@@. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, @CHEMICAL_Amoxicillin_Potassium_Clavulanate_Combination @CHEMICAL_MESH:D019980 @@@amoxicillin/clavulanic acid@@@, and @CHEMICAL_Lactic_Acid @CHEMICAL_MESH:D019344 @@@lactate@@@-containing infusions such as Ringer s @CHEMICAL_Lactic_Acid @CHEMICAL_MESH:D019344 @@@lactate@@@ should be avoided. ", "citations": {"NLM": "Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, Bali DS, El-Gharbawy A, Austin S, Pendyal S, Kishnani PS. Glycogen Storage Disease Type I . 1993;():. PMID: 20301489", "BibTeX": "@article{20301489, title={Glycogen Storage Disease Type I}, author={Adam MP and Everman DB and Mirzaa GM and Pagon RA and Wallace SE and Bean LJH and Gripp KW and Amemiya A and Bali DS and El-Gharbawy A and Austin S and Pendyal S and Kishnani PS}}"}}, {"_id": "29653414", "pmid": 29653414, "title": "New insights on the modulatory roles of metformin or alpha-lipoic acid versus their combination in dextran sulfate sodium-induced chronic colitis in rats.", "journal": "Pharmacol Rep", "authors": ["Samman FS", "Elaidy SM", "Essawy SS", "Hassan MS"], "date": "2018-06-01T00:00:00Z", "doi": "10.1016/j.pharep.2017.11.015", "meta_date_publication": "2018 Jun", "meta_volume": "70", "meta_issue": "3", "meta_pages": "488-496", "score": 50049.348, "text_hl": "BACKGROUND: @CHEMICAL_Dextran_Sulfate @CHEMICAL_MESH:D016264 @@@Dextran sulfate sodium@@@ (@CHEMICAL_Dextran_Sulfate @CHEMICAL_MESH:D016264 @@@DSS@@@)-induced @DISEASE_Colitis @DISEASE_MESH:D003092 @@@colitis@@@ is the most widely used model that resembles @<m>DISEASE_Colitis_Ulcerative</m> @DISEASE_MESH:D003093 @@@ulcerative colitis@@@ (@<m>DISEASE_Colitis_Ulcerative</m> @DISEASE_MESH:D003093 @@@UC@@@) in @SPECIES_9606 @@@human@@@ with challenging chronic mechanistic oxidative stress-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@/immunological cascades. ", "citations": {"NLM": "Samman FS, Elaidy SM, Essawy SS, Hassan MS. New insights on the modulatory roles of metformin or alpha-lipoic acid versus their combination in dextran sulfate sodium-induced chronic colitis in rats. Pharmacol Rep. 2018 Jun;70(3):488-496. PMID: 29653414", "BibTeX": "@article{29653414, title={New insights on the modulatory roles of metformin or alpha-lipoic acid versus their combination in dextran sulfate sodium-induced chronic colitis in rats.}, author={Samman FS and Elaidy SM and Essawy SS and Hassan MS}, journal={Pharmacol Rep}, volume={70}, number={3}, pages={488-496}}"}}]}